Drug Type Universal CAR-T |
Synonyms BE752TBCCLCAR7PBL, Cryopreserved BE CAR7 T cells, BE CAR-7 |
Target |
Mechanism CD7 inhibitors(T-cell antigen CD7 inhibitors), Gene transference, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Adult T-cell lymphoma/leukaemia refractory | Phase 1 | GB | 19 Apr 2022 |
Phase 1 | 3 | vjypmtzmcd(cnsgjghrpc) = cytokine release syndrome, multilineage cytopenia, and opportunistic infections. qdqjvxzhah (atjxzamvhx ) View more | - | 07 Sep 2023 |